125 results
Page 6 of 7
424B3
sblhfvrnq9wlom0majn
26 Oct 15
Prospectus supplement
12:00am
424B3
9mevecwd81jjbz0q 3hw
10 Apr 15
Prospectus supplement
12:00am
10-K
r562yhz2 x8yv6
25 Mar 15
Annual report
12:00am
424B3
38q7wr gzrhlhxesy
26 Feb 15
Prospectus supplement
12:00am
8-K
EX-10.1
3scbdledg5
3 Feb 15
Recro Pharma Enters into Common Stock Purchase Agreement with Aspire Capital
12:00am
8-K
EX-99.2
35rectzu8 o9gsg36m9
10 Nov 14
Recro Pharma Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
xvq40r
10 Nov 14
Recro Pharma Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
twojieug7v
30 Oct 14
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
12:00am
8-K
EX-99.2
l5upt0tl sn
9 Sep 14
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
12:00am
8-K
EX-99.1
cl54aev
12 Aug 14
Recro Pharma Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
yn88g7lih2
17 Jun 14
Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
12:00am
8-K
EX-99.1
wc7415yo
1 Apr 14
This presentation includes forward-looking statements within the meaning of Section
12:00am
424B4
yzsqulw5 h5uaj78
7 Mar 14
Prospectus supplement with pricing info
12:00am
S-1/A
EX-10.1
co81yjde 1o
29 Nov 13
IPO registration (amended)
12:00am